Opening Statement from the February 2017 Intelligent Investor

Opening Statement from the February 2017 Intelligent Investor

Originally published on February 9, 2017  (pre-market release)

Overview

Financials continue to outperform, as investors remain confident Trump will at least get certain portions of the Dodd Frank law repealed as well as alter (if not repeal) the new financial products fiduciary rule scheduled to take effect in a couple of months. ¹

In contrast, select pharma and biotechs continue to experience a great deal of volatility as talks heat up regarding drug price controls for the public healthcare system.

Despite the